PeterDBeitschMDFACS

PubMed

• Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative Breast Cancer.
  Alejandro Ríos-Hoyo, Thomas A Buchholz, Laura Esserman, Laura J van 't Veer, Erin Cobain, Laura A Huppert, Peter D Beitsch, Hope S Rugo, Lajos Pusztai> ;Journal of Clinical Oncology. 2024 Apr 9
• 1 citations
  Cascade testing for hereditary cancer: comprehensive multigene panels identify unexpected actionable findings in relatives.
  Brandie Heald, Sara Pirzadeh-Miller, Rachel E Ellsworth, Sarah M Nielsen, Emily M Russell, Peter Beitsch, Robert L Nussbaum, Daniel E Pineda-Alvarez, Allison W Kurian,...> ;Journal of the National Cancer Institute. 2024 Feb 8
• Combined 70- and 80-gene signatures identify tumors with genomically luminal biology responsive to neoadjuvant endocrine therapy and are prognostic of 5-year outcome i...
  James V Pellicane, Peter D Beitsch, David T Rock, Raye J Budway, Carrie L Dul, Pond R Kelemen, Andrew Y Ashikari, Paul L Baron, Paul D Weinstein, Angela Mislowsky, Lau...> ;Surgical Oncology. 2022 Dec 1
• 7 citations
  Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer.
  Curcio, L. D., Esplin, E. D., Pat W Whitworth, Peter D Beitsch, Rakesh Patel, Barry Rosen, Gia Compagnoni, Paul L Baron, Rache Simmons, Eric A Brown, Linsey Gold, Denn...> ;JAMA Network Open. 2022 Sep 1
• 17 citations
  Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial.
  , Crystal, J., Thompson, J., Hyngstrom, J., Caracò, C., Zager, J., Jahkola, T., Bowles, T., Pennacchioli, E., Beitsch, P., Hoekstra, H., Moncrieff, M., Ingvar, C., van...> ;JAMA Surgery. 2022 Sep 1
• 3 citations
  Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy.
  Pat W Whitworth, Peter D Beitsch, Mary K Murray, Paul D Richards, Angela Mislowsky, Carrie L Dul, James V Pellicane, Paul L Baron, Rakhshanda Layeequr Rahman, Laura A ...> ;JCO Precision Oncology. 2022 Sep 1
• 8 citations
  Clinical Impact of Intraoperative Margin Assessment in Breast-Conserving Surgery With a Novel Pegulicianine Fluorescence-Guided System: A Nonrandomized Controlled Trial.
  E Shelley Hwang, Peter Beitsch, Peter Blumencranz, David Carr, Anees Chagpar, Lynne Clark, Nayana Dekhne, Daleela Dodge, Donna L Dyess, Linsey Gold, Stephen Grobmyer, ...> ;JAMA Surgery. 2022 Jul 1
• 5 citations
  Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer.
  Pat Whitworth, Peter D Beitsch, James V Pellicane, Paul L Baron, Laura A Lee, Carrie L Dul, Charles H Nash 3rd, Mary K Murray, Paul D Richards, Mark Gittleman, Raye Bu...> ;Annals of Surgical Oncology. 2022 Apr 4
• 5 citations
  Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Tum...
  Pat W Whitworth, Peter D Beitsch, James V Pellicane, Paul L Baron, Laura A Lee, Carrie L Dul, Mary K Murray, Mark A Gittleman, Raye J Budway, Rakhshanda Layeequr Rahma...> ;JCO Precision Oncology. 2022 Apr 1
• 6 citations
  Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence.
  Craig L. Slingluff, Karl D. Lewis, Robert H.I. Andtbacka, John R. Hyngstrom, Mohammed M. Milhem, Svetomir N. Markovic, Tawnya L. Bowles, Omid Hamid, Leonel Hernandez-A...> ;Journal for Immunotherapy of Cancer. 2021 Oct 1
• 17 citations
  Integrating 31-Gene Expression Profiling With Clinicopathologic Features to Optimize Cutaneous Melanoma Sentinel Lymph Node Metastasis Prediction.
  Eric D. Whitman, Vadim P. Koshenkov, Brian R. Gastman, Deri Lewis, Eddy C. Hsueh, Ho Pak, Thomas P. Trezona, Robert S. Davidson, Michael McPhee, J. Michael Guenther, P...> ;JCO Precision Oncology. 2021 Sep 13
• 13 citations
  Preoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does not Provide Reliable Nodal Staging: Results From a Large Multicenter Trial.
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Annals of Surgery. 2021 Apr 1
• Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Node...
  Michael Alvarado, Elizabeth A. Mittendorf, Mediget Teshome, Alastair M. Thompson, Richard J. Bold, Mark A. Gittleman, Peter D. Beitsch, Sarah L. Blair, Kaisa Kivilaid,...> ;Annals of Surgical Oncology. 2020 Jan 1
• 5 citations
  Response to the article by Dietz et al. entitled "Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID­19 pandemic. The...
  Peter D. Beitsch, Pat Whitworth, Rakesh Patel> ;Breast Cancer Research and Treatment. 2020 May 26
• 38 citations
  SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients w...
  Michael Alvarado, Elizabeth A. Mittendorf, Mediget Teshome, Alastair M. Thompson, Richard J. Bold, Mark A. Gittleman, Peter D. Beitsch, Sarah L. Blair, Kaisa Kivilaid,...> ;Annals of Surgical Oncology. 2019 Jul 11
• 4 citations
  Reply to M.S. Copur et al, A. Taylor et al, and P.S. Rajagopal et al
  Peter D. Beitsch, Kevin S. Hughes, Pat Whitworth> ;Journal of Clinical Oncology. 2019 Jun 27
• 24 citations
  Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers.
  Floris H. Groenendijk, Tina Treece, Erin Yoder, Paul L. Baron, Peter D. Beitsch, William Audeh, Winand N.M. Dinjens, René Bernards, Pat Whitworth> ;NPJ Breast Cancer. 2019 Apr 18
• Guidelines Do Not Proscribe Surgeons Performing Genetic Testing.
  Kevin S. Hughes, Peter D. Beitsch, Steven Chen> ;JAMA Surgery. 2019 Mar 1
• 209 citations
  Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
  Esplin, E. D., Peter D. Beitsch, Pat Whitworth, Kevin S. Hughes, Rakesh R. Patel, Barry Rosen, Gia Compagnoni, P Baron, Rache M. Simmons, Linda Ann Smith, Ian Grady, M...> ;Journal of Clinical Oncology. 2019 Feb 20
• 9 citations
  BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer.
  Mi Jeong Kwon, Sae Byul Lee, Jinil Han, Jeong Eon Lee, Jong Won Lee, Gyungyub Gong, Peter D Beitsch, Seok Jin Nam, Sei Hyun Ahn, Byung-Ho Nam, Young Kee Shin> ;Plos One. 2018 Nov 21
• 28 citations
  Evidence based outcomes of the American Society of Breast Surgeons Nipple Sparing Mastectomy Registry
  Sunny D. Mitchell, Shawna C. Willey, Peter D. Beitsch, Sheldon Feldman> ;Gland Surgery. 2018 Jun 1
• 922 citations
  Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0...
  Armando E. Giuliano, Karla V. Ballman, Linda M. McCall, Peter D. Beitsch, Meghan Brennan, Pond R. Kelemen, David W. Ollila, Nora M. Hansen, Pat Whitworth, Peter W. Blu...> ;JAMA. 2017 Sep 12
• 826 citations
  Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
  Mark B. Faries, John F. Thompson, Alistair J. Cochran, Robert H.I. Andtbacka, Nicola Mozzillo, Jonathan S. Zager, Tiina Jahkola, Tawnya L. Bowles, Alessandro Testori, ...> ;The New England Journal of Medicine. 2017 Jun 8
• 29 citations
  Pertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+ Breast Cancer: Results from the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST).
  Peter D. Beitsch, Pat Whitworth, Paul L. Baron, Michael Rotkis, Angela Mislowsky, Paul Richards, Mary Murray, James Pellicane, Carrie L. Dul, Charles Nash, Lisette Sto...> ;Annals of Surgical Oncology. 2017 Apr 26
• 33 citations
  Impact of Payer Constraints on Access to Genetic Testing
  Pat Whitworth, Peter D. Beitsch, Christopher Arnell, Hannah C. Cox, Krystal Brown, John Kidd, Johnathan M. Lancaster> ;Journal of Oncology Practice. 2017 Jan 1
• Join now to see all